Search

everythinglearnresearchcommunity

for

Search:↓

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

Method accurately measures finasteride in tablets using finasteride-BSA interaction.

Women with AGA have higher lipid levels, increasing heart disease risk.

The guidelines ensure accurate genetic testing and reporting for 21-hydroxylase deficiency.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Ultrasound measurement of the ovarian stroma to total area ratio is not a reliable single predictor of high male hormone levels in Thai women with PCOS, but works better when combined with clinical signs.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

PCOS is common, affects fertility, and requires personalized treatment to manage symptoms and health risks.

High-intensity interval training (HIIT) is better than moderate-intensity continuous training (MICT) for improving health in overweight women with PCOS.

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

Hair loss linked to higher heart disease risk in both men and women.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

Hair loss in young men linked to higher risk of insulin resistance and metabolic issues.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

Finasteride reduces hair growth and is safe for women with excessive hair.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Larger ovarian size is linked to higher insulin resistance in women with PCOS.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

Longer GGN repeats in the androgen receptor gene are linked to polycystic ovary syndrome.

Polycystic ovary syndrome (PCOS) is a major health issue for women in Egypt, affecting 14% of fertile women and 37.5% of infertile women.

Male pattern baldness may be caused by factors like poor blood circulation, scalp tension, stress, and hormonal imbalances, but the exact causes are still unclear.

Nearly half of women with PCOS have metabolic syndrome, and lifestyle changes are crucial to prevent complications.